Lucky Rooster? A Stellar Year Ahead For Chinese Pharma Investment

If the year of the Monkey is a jumpy ride filled with uncertainties, the coming year of the Rooster will be certain to bring more changes to the pharma sector and immuno-oncology, high-end devices and combining artificial intelligence with next-generation genomics are attracting large amount of hot cash inflow.